Oana Vlad

New Insights on Using Oral Semaglutide versus Dapagliflozin in Patients with Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease

A. Sîngeap, A. Trifan, T. Cuciureanu, 2024, Diagnostics.